Tuscan Ridge Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tuscan Ridge Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-24,350	Closed	-$2.02M	–	813
2019 Q2	$2.14M	Buy	24,350 +14,104	+138%	+$1.2M	0.17%	183
2019 Q1	$928K	Buy	+10,246	New	+$872K	0.07%	342

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Tuscan Ridge Asset Management's XBI Position: Q3 2019 in Review

Tuscan Ridge Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2019, closing a stake of 24,350 shares — an estimated $2.02M sold.

Tuscan Ridge Asset Management first reported a position in XBI in Q1 2019 and held it in 2 quarters. The position peaked at $2.14M in Q2 2019. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.

Tuscan Ridge Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2019 after selling out during the quarter.
Tuscan Ridge Asset Management sold 24,350 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $2.02M.
Tuscan Ridge Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 2 quarters.
Tuscan Ridge Asset Management's State Street SPDR S&P Biotech ETF position peaked at $2.14M in Q2 2019.
406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.

Based on Tuscan Ridge Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.